This volume brings together the work of leading medical chemists and represents efforts on the part of drug designers to produce small molecules aimed at preventing or treating brain-related diseases. Prominent among these are contributions on agents of value in Alzheimer's therapy; anxioselective anxiolytics; novel antipsychotics and the activation of dopamine autoreceptors; the role of the neurotransmitter dopamine in cocaine addiction; multiple populations of serotonin receptors; designing specific 5-HT3 receptor antagonists; glutamatergic receptor modulation; developing compounds capable of interacting with second messenger systems; and brain targeting of biologically active compounds. Also featured are examples of computer-assisted molecular modelling (CAMM) described throughout the text.
"synopsis" may belong to another edition of this title.
Seller: PsychoBabel & Skoob Books, Didcot, United Kingdom
Hardcover. Condition: Very Good. 1st Edition. Hardcover, no jacket; printed boards, first edition; first printing, very good condition. A very clean copy overall with only minor compression to the spine ends. Internally excellent throughout. DP. Used. Seller Inventory # 513413
Quantity: 1 available
Seller: Mispah books, Redhill, SURRE, United Kingdom
hardcover. Condition: Very Good. Very Good. Dust Jacket may NOT BE INCLUDED.CDs may be missing. SHIPS FROM MULTIPLE LOCATIONS. book. Seller Inventory # ERICA82907817006125
Quantity: 1 available